Pfizer Selling Capsugel for $2.4B to KKR

PEAPACK, New Jersey ( TheStreet) -- Pfizer ( PFE) said Monday it agreed to sell its Capsugel business for $2.375 billion in cash to Kohlberg Kravis Roberts ( KKR).

Pfizer, in a statement Monday, said its Capsugel business had 2010 revenue of $750 million and manufactured more than 180 billion hard capsules during the year, making Capsugel the world leader in hard capsules.

As a result of the deal, Pfizer said it updated its expected 2011 reported revenue range to $65.2 billion to $67.2 billion from $66 billion to $68 billion. The company also said it now expects 2012 revenue of $62.2 billion to $64.7 billion from a previous forecast of $63 billion to $65.2 billion.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

More from Stocks

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

GE's $11.1 Billion Deal With Wabtec Should Have Warren Buffett Feeling Very Sad

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

China Trade Truce, General Electric and Tesla - 5 Things You Must Know

China Trade Truce, General Electric and Tesla - 5 Things You Must Know

The Stock Market Has Every Reason to See a Fresh Rally

The Stock Market Has Every Reason to See a Fresh Rally

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming

18 Top Stocks Hedge Funds Own That Goldman Sachs Thinks Will Keep Outperforming